Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1996 Dec 1;98(11):2612–2615. doi: 10.1172/JCI119081

Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3.

M Harrela 1, H Koistinen 1, J Kaprio 1, M Lehtovirta 1, J Tuomilehto 1, J Eriksson 1, L Toivanen 1, M Koskenvuo 1, P Leinonen 1, R Koistinen 1, M Seppälä 1
PMCID: PMC507720  PMID: 8958225

Abstract

We assessed the magnitude of the genetic component in the variation of circulating levels of insulin-like growth factors I and II (IGF-I and IGF-II), and their binding proteins IGFBP-1 and IGFBP-3 by measuring their serum concentrations in 32 monozygotic and 47 dizygotic adult twin pairs of the same sex. The intrapair correlation for the IGF-I levels was r = 0.41 (P < 0.009) for monozygotic twins and r = 0.12 (P < 0.22) for dizygotic twins. For the IGF-II concentration the intrapair correlations were r = 0.66 (P < 0.0001) for the monozygotic and r = 0.34 (P < 0.01) for the dizygotic twins. No significant intrapair correlation was found for IGFBP-1 levels in either group. The correlations for IGFBP-3 concentration were r = 0.65 (P < 0.0001) and r = 0.23 (P < 0.06) for monozygotic and dizygotic twins, respectively. Women had higher IGF-II levels than men (635+/-175 vs. 522+/-144 microg/liter; P < 0.0001) and IGFBP-3 levels were also higher in women compared with men (5441+/-1018 vs. 4496+/-1084 microg/liter; P < 0.001). The proportion of variance attributable to genetic effects was 38% for the IGF-I concentration, 66% for the IGF-II concentration, and 60% for the IGFBP-3 concentration. No significant heritability was found for the IGFBP-1 concentrations. Our results show that, in adults, there is a substantial genetic contribution responsible for interindividual variation of the circulating levels of IGF-I, IGF-II, and IGFBP-3, but not for the IGFBP-1 levels.

Full Text

The Full Text of this article is available as a PDF (149.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alitalo T., Kontula K., Koistinen R., Aalto-Setälä K., Julkunen M., Jänne O. A., Seppälä M., de la Chapelle A. The gene encoding human low-molecular weight insulin-like growth-factor binding protein (IGF-BP25): regional localization to 7p12-p13 and description of a DNA polymorphism. Hum Genet. 1989 Nov;83(4):335–338. doi: 10.1007/BF00291377. [DOI] [PubMed] [Google Scholar]
  2. Angervo M., Leinonen P., Koistinen R., Julkunen M., Seppälä M. Tri-iodothyronine and cycloheximide enhance insulin-like growth factor-binding protein-1 gene expression in human hepatoma cells. J Mol Endocrinol. 1993 Feb;10(1):7–13. doi: 10.1677/jme.0.0100007. [DOI] [PubMed] [Google Scholar]
  3. Angervo M., Toivonen J., Leinonen P., Välimäki M., Seppälä M. Thyroxine withdrawal is accompanied by decreased circulating levels of insulin-like growth factor-binding protein-1 in thyroidectomized patients. J Clin Endocrinol Metab. 1993 May;76(5):1199–1201. doi: 10.1210/jcem.76.5.7684392. [DOI] [PubMed] [Google Scholar]
  4. Baxter R. C., Martin J. L. Binding proteins for the insulin-like growth factors: structure, regulation and function. Prog Growth Factor Res. 1989;1(1):49–68. doi: 10.1016/0955-2235(89)90041-0. [DOI] [PubMed] [Google Scholar]
  5. Bereket A., Lang C. H., Blethen S. L., Fan J., Frost R. A., Wilson T. A. Insulin-like growth factor binding protein-3 proteolysis in children with insulin-dependent diabetes mellitus: a possible role for insulin in the regulation of IGFBP-3 protease activity. J Clin Endocrinol Metab. 1995 Aug;80(8):2282–2288. doi: 10.1210/jcem.80.8.7543110. [DOI] [PubMed] [Google Scholar]
  6. Blum W. F., Albertsson-Wikland K., Rosberg S., Ranke M. B. Serum levels of insulin-like growth factor I (IGF-I) and IGF binding protein 3 reflect spontaneous growth hormone secretion. J Clin Endocrinol Metab. 1993 Jun;76(6):1610–1616. doi: 10.1210/jcem.76.6.7684744. [DOI] [PubMed] [Google Scholar]
  7. Cohen K. L., Nissley S. P. The serum half-life of somatomedin activity: evidence for growth hormone dependence. Acta Endocrinol (Copenh) 1976 Oct;83(2):243–258. doi: 10.1530/acta.0.0830243. [DOI] [PubMed] [Google Scholar]
  8. Daughaday W. H., Rotwein P. Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev. 1989 Feb;10(1):68–91. doi: 10.1210/edrv-10-1-68. [DOI] [PubMed] [Google Scholar]
  9. Davenport M. L., Clemmons D. R., Miles M. V., Camacho-Hubner C., D'Ercole A. J., Underwood L. E. Regulation of serum insulin-like growth factor-I (IGF-I) and IGF binding proteins during rat pregnancy. Endocrinology. 1990 Sep;127(3):1278–1286. doi: 10.1210/endo-127-3-1278. [DOI] [PubMed] [Google Scholar]
  10. Davenport M. L., Isley W. L., Pucilowska J. B., Pemberton L. B., Lyman B., Underwood L. E., Clemmons D. R. Insulin-like growth factor-binding protein-3 proteolysis is induced after elective surgery. J Clin Endocrinol Metab. 1992 Aug;75(2):590–595. doi: 10.1210/jcem.75.2.1379257. [DOI] [PubMed] [Google Scholar]
  11. Davies S. C., Wass J. A., Ross R. J., Cotterill A. M., Buchanan C. R., Coulson V. J., Holly J. M. The induction of a specific protease for insulin-like growth factor binding protein-3 in the circulation during severe illness. J Endocrinol. 1991 Sep;130(3):469–473. doi: 10.1677/joe.0.1300469. [DOI] [PubMed] [Google Scholar]
  12. Ehrenborg E., Larsson C., Stern I., Janson M., Powell D. R., Luthman H. Contiguous localization of the genes encoding human insulin-like growth factor binding proteins 1 (IGBP1) and 3 (IGBP3) on chromosome 7. Genomics. 1992 Mar;12(3):497–502. doi: 10.1016/0888-7543(92)90440-4. [DOI] [PubMed] [Google Scholar]
  13. Giudice L. C., Farrell E. M., Pham H., Lamson G., Rosenfeld R. G. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: effects of a pregnancy-associated serum protease activity. J Clin Endocrinol Metab. 1990 Oct;71(4):806–816. doi: 10.1210/jcem-71-4-806. [DOI] [PubMed] [Google Scholar]
  14. Giudice L. C. IGF binding protein-3 protease regulation: how sweet it is! J Clin Endocrinol Metab. 1995 Aug;80(8):2279–2281. doi: 10.1210/jcem.80.8.7543109. [DOI] [PubMed] [Google Scholar]
  15. Hall K., Sara V. R. Somatomedin levels in childhood, adolescence and adult life. Clin Endocrinol Metab. 1984 Mar;13(1):91–112. doi: 10.1016/s0300-595x(84)80010-9. [DOI] [PubMed] [Google Scholar]
  16. Hintz R. L., Liu F., Rosenfeld R. G., Kemp S. F. Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy. J Clin Endocrinol Metab. 1981 Jul;53(1):100–104. doi: 10.1210/jcem-53-1-100. [DOI] [PubMed] [Google Scholar]
  17. Jahanfar S., Eden J. A., Warren P., Seppälä M., Nguyen T. V. A twin study of polycystic ovary syndrome. Fertil Steril. 1995 Mar;63(3):478–486. [PubMed] [Google Scholar]
  18. Kao P. C., Matheny A. P., Jr, Lang C. A. Insulin-like growth factor-I comparisons in healthy twin children. J Clin Endocrinol Metab. 1994 Feb;78(2):310–312. doi: 10.1210/jcem.78.2.8106617. [DOI] [PubMed] [Google Scholar]
  19. Kaprio J., Sarna S., Koskenvuo M., Rantasalo I. The Finnish Twin Registry: formation and compilation, questionnaire study, zygosity determination procedures, and research program. Prog Clin Biol Res. 1978;24(Pt B):179–184. [PubMed] [Google Scholar]
  20. Koistinen H., Koistinen R., Selenius L., Ylikorkala Q., Seppälä M. Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. J Appl Physiol (1985) 1996 Mar;80(3):760–764. doi: 10.1152/jappl.1996.80.3.760. [DOI] [PubMed] [Google Scholar]
  21. Koistinen H., Seppälä M., Koistinen R. Different forms of insulin-like growth factor-binding protein-3 detected in serum and seminal plasma by immunofluorometric assay with monoclonal antibodies. Clin Chem. 1994 Apr;40(4):531–536. [PubMed] [Google Scholar]
  22. Koistinen R., Itkonen O., Selenius P., Seppälä M. Insulin-like growth factor-binding protein-1 inhibits binding of IGF-I on fetal skin fibroblasts but stimulates their DNA synthesis. Biochem Biophys Res Commun. 1990 Nov 30;173(1):408–415. doi: 10.1016/s0006-291x(05)81073-3. [DOI] [PubMed] [Google Scholar]
  23. Sarna S., Kaprio J., Sistonen P., Koskenvuo M. Diagnosis of twin zygosity by mailed questionnaire. Hum Hered. 1978;28(4):241–254. doi: 10.1159/000152964. [DOI] [PubMed] [Google Scholar]
  24. Shimasaki S., Ling N. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res. 1991;3(4):243–266. doi: 10.1016/0955-2235(91)90003-m. [DOI] [PubMed] [Google Scholar]
  25. Suikkari A. M., Koivisto V. A., Rutanen E. M., Yki-Järvinen H., Karonen S. L., Seppälä M. Insulin regulates the serum levels of low molecular weight insulin-like growth factor-binding protein. J Clin Endocrinol Metab. 1988 Feb;66(2):266–272. doi: 10.1210/jcem-66-2-266. [DOI] [PubMed] [Google Scholar]
  26. Ullrich A., Berman C. H., Dull T. J., Gray A., Lee J. M. Isolation of the human insulin-like growth factor I gene using a single synthetic DNA probe. EMBO J. 1984 Feb;3(2):361–364. doi: 10.1002/j.1460-2075.1984.tb01812.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Vihervuori E., Virtanen M., Koistinen H., Koistinen R., Seppälä M., Siimes M. A. Hemoglobin level is linked to growth hormone-dependent proteins in short children. Blood. 1996 Mar 1;87(5):2075–2081. [PubMed] [Google Scholar]
  28. Williams C. J., Christian J. C., Norton J. A., Jr TWINAN90: a FORTRAN program for conducting ANOVA-based and likelihood-based analyses of twin data. Comput Methods Programs Biomed. 1992 Jul;38(2-3):167–176. doi: 10.1016/0169-2607(92)90084-k. [DOI] [PubMed] [Google Scholar]
  29. de Pagter-Holthuizen P., van Schaik F. M., Verduijn G. M., van Ommen G. J., Bouma B. N., Jansen M., Sussenbach J. S. Organization of the human genes for insulin-like growth factors I and II. FEBS Lett. 1986 Jan 20;195(1-2):179–184. doi: 10.1016/0014-5793(86)80156-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES